JPMorgan Chase & Co. lifted its stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU – Free Report) by 18,000.0% in the third quarter, HoldingsChannel.com reports. The fund owned 905 shares of the technology company’s stock after acquiring an additional 900 shares during the quarter. JPMorgan Chase & Co.’s holdings in Kewaunee Scientific were worth $30,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC purchased a new stake in Kewaunee Scientific during the 3rd quarter valued at $121,000. Geode Capital Management LLC lifted its position in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after buying an additional 1,941 shares during the period. State Street Corp bought a new stake in Kewaunee Scientific during the third quarter worth about $266,000. De Lisle Partners LLP increased its position in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares in the last quarter. Finally, Ritholtz Wealth Management increased its holdings in shares of Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after acquiring an additional 2,156 shares in the last quarter. Institutional investors own 32.69% of the company’s stock.
Insider Transactions at Kewaunee Scientific
In other news, CFO Donald T. Gardner III sold 1,257 shares of the stock in a transaction on Friday, January 10th. The shares were sold at an average price of $59.26, for a total value of $74,489.82. Following the sale, the chief financial officer now owns 21,358 shares in the company, valued at $1,265,675.08. This represents a 5.56 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Thomas David Hull III sold 1,368 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $60.08, for a total value of $82,189.44. Following the completion of the sale, the chief executive officer now directly owns 41,129 shares in the company, valued at approximately $2,471,030.32. The trade was a 3.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,994 shares of company stock worth $729,430. Insiders own 14.20% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Research Report on KEQU
Kewaunee Scientific Stock Up 3.4 %
Shares of KEQU stock opened at $64.26 on Wednesday. The company’s fifty day moving average price is $55.42 and its 200-day moving average price is $46.63. Kewaunee Scientific Co. has a one year low of $27.00 and a one year high of $67.20. The company has a market capitalization of $184.55 million, a price-to-earnings ratio of 10.18 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last released its quarterly earnings results on Wednesday, December 11th. The technology company reported $1.41 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories
- Five stocks we like better than Kewaunee Scientific
- Investing in Construction Stocks
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Invest in the FAANG Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What Investors Need to Know to Beat the Market
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding KEQU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kewaunee Scientific Co. (NASDAQ:KEQU – Free Report).
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.